{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:13Z","timestamp":1786119673490,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/mbc.0b013e328343f928","type":"journal-article","created":{"date-parts":[[2011,2,5]],"date-time":"2011-02-05T02:06:26Z","timestamp":1296871586000},"page":"227-230","source":"Crossref","is-referenced-by-count":8,"title":["A novel factor XII mutation, FXII R84P, causing factor XII deficiency in a patient with hereditary spastic paraplegia"],"prefix":"10.1097","volume":"22","author":[{"given":"Eri","family":"Matsuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210203","doi-asserted-by":"crossref","first-page":"13666","DOI":"10.1016\/S0021-9258(17)38776-8","article-title":"Characterization of human blood coagulation factor XII cDNA","volume":"260","author":"Cool","year":"1985","journal-title":"J Biol Chem"},{"key":"R2-12-20210203","doi-asserted-by":"crossref","first-page":"13662","DOI":"10.1016\/S0021-9258(19)76478-3","article-title":"Characterization of the human blood coagulation factor XII gene","volume":"262","author":"Cool","year":"1987","journal-title":"J Biol Chem"},{"key":"R3-12-20210203","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1432-1033.1996.0240q.x","article-title":"Structure\/function analysis of human factor XII using recombinant deletion mutants","volume":"238","author":"Citarella","year":"1996","journal-title":"Eur J Biochem"},{"key":"R4-12-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-3848(93)90168-N","article-title":"Structural biology, cellular interactions and pathophysiology of the contact system","volume":"72","author":"Wachtfogel","year":"1993","journal-title":"Thromb Res"},{"key":"R5-12-20210203","first-page":"3967","article-title":"Mutations in the human factor XII gene","volume":"90","author":"Schloesser","year":"1997","journal-title":"Blood"},{"key":"R6-12-20210203","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000173722","article-title":"Major and potential prothrombotic genotypes in patients with venous thrombosis and in healthy subjects from Slovenia","volume":"36","author":"Bedencic","year":"2007","journal-title":"Pathophysiol Haemost Thromb"},{"key":"R7-12-20210203","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00019501-199405000-00012","article-title":"Prevalence of factor XII (Hageman factor) deficiency among 426 patients with coronary heart disease awaiting cardiac surgery","volume":"5","author":"Halbmayer","year":"1994","journal-title":"Coron Artery Dis"},{"key":"R8-12-20210203","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1046\/j.1365-2141.2001.03201.x","article-title":"Homozygosity for the C\u2192T polymorphism at nucleotide 46 in the 5\u2032 untranslated region of the factor XII gene protects from development of acute coronary syndrome","volume":"115","author":"Endler","year":"2001","journal-title":"Br J Haematol"},{"key":"R9-12-20210203","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(00)00404-7","article-title":"A common C\u2192T polymorphism at nt 46 in the promoter region of coagulation factor XII is associated with decreased factor XII activity","volume":"101","author":"Endler","year":"2001","journal-title":"Thromb Res"},{"key":"R10-12-20210203","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1182\/blood.V93.12.4300","article-title":"Factor XII Tenri, a novel cross-reacting material negative factor XII deficiency, occurs through a proteasome-mediated degradation","volume":"93","author":"Kondo","year":"1999","journal-title":"Blood"},{"key":"R11-12-20210203","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.thromres.2004.08.027","article-title":"Factor XII Shizuoka, a novel mutation (Ala392Thr) identified and characterized in a patient with congenital coagulation factor XII deficiency","volume":"115","author":"Oguchi","year":"2005","journal-title":"Thromb Res"},{"key":"R12-12-20210203","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0037-1613599","article-title":"Molecular characterization of coagulation factor XII deficiency in a Japanese family","volume":"90","author":"Wada","year":"2003","journal-title":"Thromb Haemost"},{"key":"R13-12-20210203","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.mbc.0000114447.59147.d1","article-title":"Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency","volume":"15","author":"Ishii","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R14-12-20210203","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.thromres.2009.12.004","article-title":"Factor XII Ofunato: Lys346Asn mutation associated with blood coagulation factor XII deficiency causes impaired secretion through a proteasome-mediated degradation","volume":"125","author":"Suzuki","year":"2010","journal-title":"Thromb Res"},{"key":"R15-12-20210203","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1055\/s-0037-1616743","article-title":"Identification and characterization of two novel mutations (Q421K and R123P) in congenital factor XII deficiency","volume":"86","author":"Kanaji","year":"2001","journal-title":"Thromb Haemost"},{"key":"R16-12-20210203","doi-asserted-by":"crossref","first-page":"8319","DOI":"10.1073\/pnas.86.21.8319","article-title":"Coagulation factor XII (hageman factor) Washington D.C.: inactive factor XIIa results from Cys-571 to Ser substitution","volume":"86","author":"Miyata","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-12-20210203","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood.V84.4.1173.1173","article-title":"Coagulation factor XII Locarno: the functional defect is caused by the amino acid substitution Arg353\u2192Pro leading to loss of a kallikrein cleavage site","volume":"84","author":"Hovinga","year":"1994","journal-title":"Blood"},{"key":"R18-12-20210203","first-page":"851","article-title":"Two siblings of familial spastic paraplegia associated with decreased levels of factor XII","volume":"26","author":"Fujii","year":"1986","journal-title":"Clin Neurol"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-201104000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:52:16Z","timestamp":1786042336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-201104000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e328343f928","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}